Intra-Cellular Therapies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. 

CEO
Sharon Mates
CEOSharon Mates
Employees
512
Employees512
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2002
Founded2002
Employees
512
Employees512

ITCI Key Statistics

Market cap
4.11B
Market cap4.11B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
794.13K
Average volume794.13K
High today
$45.60
High today$45.60
Low today
$43.02
Low today$43.02
Open price
$45.60
Open price$45.60
Volume
912.53K
Volume912.53K
52 Week high
$66.00
52 Week high$66.00
52 Week low
$34.43
52 Week low$34.43

Analyst ratings

85%

of 13 ratings
Buy
84.6%
Hold
15.4%
Sell
0%

ITCI Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.